- Inspira Technologies (IINN, Financial) undergoes leadership restructuring without appointing a new President.
- Co-Founder Joe Hayon steps down from operational role but remains on the Board, ensuring strategic continuity.
- CEO Dagi Ben-Noon confirms no disruption to ongoing operations or R&D timelines.
Inspira Technologies (IINN), a leader in advanced respiratory support and diagnostic systems, announced significant changes in its executive team. Co-Founder and President, Joe Hayon, will step down from his operational duties, while continuing his involvement as an active Board member. The company will not appoint a new President, aiming to simplify its leadership structure as part of broader corporate restructuring initiatives.
This strategic transition is aimed at enhancing operational clarity and improving institutional readiness amid a rapidly evolving market. Inspira Technologies' CEO, Dagi Ben-Noon, reassured stakeholders that the leadership change will not affect current operations or research and development schedules.
Inspira remains committed to advancing its proprietary respiratory technologies portfolio, adapting to market consolidation, and exploring cross-sector opportunities. The ongoing internal adjustments are intended to align the company's operations with long-term strategic goals and industry trends.
The company's commitment to innovation in the healthcare sector is further evidenced by its FDA-cleared INSPIRA ART100 system and the ongoing development of the next-generation INSPIRA ART500 system, designed for use during awake patient procedures. Inspira continues to be a prominent player in the MedTech landscape, driven by a strong IP portfolio and refined governance structure.
